Renhao Xue

8PUBLICATIONS
10CO-AUTHORS
Molecular targetsCancer cell biologyCancer geneticsMicrofluidics and nanofluidicsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 09, 2026
SUMOylated Reptin maintains low intracellular ROS levels by activating mitophagy to drive gemcitabine resistance in gallbladder cancer.

|Jun 29, 2026
Targeting EZH2-driven cholesterol metabolic vulnerability through Napabucasin suppresses ovarian cancer metastasis.

|Feb 27, 2026
CRISP3, a Potential Tumor Suppressor, Inhibits the Progression of High-Grade Serous Ovarian Carcinoma by Modulating the PI3K/AKT Pathway.

Mingjun Ma, Xiu Tian, Weiwei Cao

|Aug 04, 2025
Profiling of RUVBL2-Induced Transcriptome Alterations Highlights a Critical Role for Chromatin Remodeling in Ovarian Cancer.

Renhao Xue, Yingjie Wang, Xiaomei Luo

|Feb 14, 2024
Pre-fusion motion state determines the heterogeneity of membrane fusion dynamics for large dense-core vesicles.

Renhao Xue, Enming Zhang, Yu Wang

|Dec 23, 2023
Identification of a Prognostic Signature for Ovarian Cancer Based on Ubiquitin-Related Genes Suggesting a Potential Role for FBXO9.

Xiaomei Luo, Yingjie Wang, Hao Zhang

Pageof 2

Frequent Collaborators

2 joint publications

Chen Chu

2 joint publications

Jindan Sheng

2 joint publications

Yu Wang

1 joint publications

Yingjie Wang